<- Go Home
Stratec SE
Stratec SE, together with its subsidiaries, provides automation solutions for in-vitro diagnostics and life science companies in Germany, the European Union, and internationally. The company designs and manufactures automated analyzer systems for clinical diagnostics and biotechnology customers. It also provides consumables for diagnostics and medical applications; and instrumentation and software. The company was formerly known as STRATEC Biomedical AG and changed its name to Stratec SE in December 2018. Stratec SE was founded in 1979 and is headquartered in Birkenfeld, Germany.
Market Cap
EUR 267.4M
Volume
13.4K
Cash and Equivalents
EUR 19.0M
EBITDA
EUR 28.3M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
EUR 57.7M
Profit Margin
23.57%
52 Week High
EUR 33.10
52 Week Low
EUR 16.30
Dividend
N/A
Price / Book Value
1.12
Price / Earnings
-677.05
Price / Tangible Book Value
2.12
Enterprise Value
EUR 348.6M
Enterprise Value / EBITDA
10.91
Operating Income
EUR 16.8M
Return on Equity
0.17%
Return on Assets
2.52
Cash and Short Term Investments
EUR 19.0M
Debt
EUR 100.2M
Equity
EUR 238.4M
Revenue
EUR 244.8M
Unlevered FCF
EUR 30.7M
Sector
Health Care Equipment and Supplies
Category
N/A